D-0995-2019 Class III Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0995-2019 was initiated by Dr. Reddy's Laboratories, Inc. on Feb 6, 2019 and is designated Class III. Reason for recall: Discoloration: Esomeprazole Magnesium DR Capsules (40mg) may contain brown pellets. The recall status is terminated (terminated Jan 26, 2021). Affected quantity: 40,592, 90 and 1,000 count bottles.

Recall details

Product Type
Drugs
Report Date
Feb 20, 2019
Initiation Date
Feb 6, 2019
Termination Date
Jan 26, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
40,592, 90 and 1,000 count bottles

Product description

Esomeprazole Magnesium Delayed-Release Capsules USP, 40mg*, a) 90-count bottle (NDC 43598-510-90) b) 1000 count bottle (NDC 43598-510-10), Rx only, Mfd By: Dr. Reddy's Laboratories Limited Bachupally - 500 090 INDIA.

Reason for recall

Discoloration: Esomeprazole Magnesium DR Capsules (40mg) may contain brown pellets.

Distribution pattern

Distributed Nationwide in the USA

Code information

Lot #: a) C800589, Exp 5/2019; C706058, Exp 03/2019 Lot #: b) C704873 Exp 02/2019; C800951, C800953 Exp 06/2019.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0995-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0995-2019. Report a data issue: hello@regdatalab.com.